Helena Lindmark
R&D, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Development of novel high-throughput biochemical competition assays to identify ligands of human asialoglycoprotein receptor 1.
Journal: SLAS discovery : advancing life sciences R & D
Published: July 02, 2025
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma.
Journal: Journal of medicinal chemistry
Published: June 03, 2021
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
Journal: The European respiratory journal
Published: August 28, 2020
A Comparative Study of Fluorescence Assays in Screening for BRD4.
Journal: Assay and drug development technologies
Published: October 12, 2018
A class of highly selective inhibitors bind to an active state of PI3Kγ.
Journal: Nature chemical biology
Published: July 06, 2018
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 01, 2018
Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration.
Journal: Journal of medicinal chemistry
Published: May 19, 2017
Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: September 09, 2016
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.
Journal: PloS one
Published: December 02, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026